TY - JOUR
T1 - Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: Results from Diabetes MILES - Australia cross-sectional survey
AU - Holmes-Truscott, E.
AU - Holmes-Truscott, E.
AU - Skinner, T. C.
AU - Pouwer, F.
AU - Speight, J.
AU - Speight, J.
AU - Speight, J.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Aim: To identify insulin therapy appraisals among adults with Type 2 diabetes using insulin and how negative appraisals relate to clinical, self-care and psychosocial outcomes. Methods: Diabetes MILES - Australia 2011 was a national survey of adults with diabetes, focused on behavioural and psychosocial issues. Subgroup analyses were conducted on the responses of 273 adults with Type 2 diabetes using insulin (46% women; mean ± sd age: 59 ± 9 years; diabetes duration: 12 ± 7 years; years using insulin: 4 ± 4). They completed validated measures of insulin therapy appraisals (ITAS), depression (PHQ-9), anxiety (GAD-7), diabetes distress (PAID) and diabetes-specific self-efficacy (DES-SF). Results: Insulin was perceived to be very important, and its benefits (e.g. improves health) were endorsed by most (82%). Fifty-one per cent believed that taking insulin means their diabetes has become worse; 51% that insulin causes weight gain; 39% that they have 'failed to manage' their diabetes. Those with the greatest and least 'ITAS negative' scores did not differ by diabetes duration or years using insulin, or by average number of insulin injections or blood glucose checks per day. Those with more negative insulin appraisals were significantly younger (Mean Diff. = 5 years, P < 0.001), less satisfied with recent blood glucose levels (P < 0.001, d = 0.63), had reduced diabetes-specific self-efficacy (P < 0.001, d = 0.7), and were more likely to report depressive symptoms, anxiety or diabetes distress (all P < 0.001, d = 0.65-1.1). Conclusions: Negative insulin therapy appraisals are common among adults with Type 2 diabetes using insulin, and are associated with lower general and diabetes-specific emotional well-being, reduced diabetes-specific self-efficacy and satisfaction with blood glucose. What's new?: This is the first study to explicitly explore appraisals of insulin therapy among adults with Type 2 diabetes currently using insulin using validated measures. Despite insulin use, some people with Type 2 diabetes report negative appraisals of insulin therapy including physical and psychological barriers. Diabetes duration, years using insulin, injections and blood glucose checks per day do not differ between those with more and those with less negative appraisals of insulin therapy. Participants reporting more negative insulin appraisals also report poorer general and diabetes-specific emotional well-being, reduced diabetes-specific self-efficacy and satisfaction with blood glucose levels compared with those with more positive appraisals.
AB - Aim: To identify insulin therapy appraisals among adults with Type 2 diabetes using insulin and how negative appraisals relate to clinical, self-care and psychosocial outcomes. Methods: Diabetes MILES - Australia 2011 was a national survey of adults with diabetes, focused on behavioural and psychosocial issues. Subgroup analyses were conducted on the responses of 273 adults with Type 2 diabetes using insulin (46% women; mean ± sd age: 59 ± 9 years; diabetes duration: 12 ± 7 years; years using insulin: 4 ± 4). They completed validated measures of insulin therapy appraisals (ITAS), depression (PHQ-9), anxiety (GAD-7), diabetes distress (PAID) and diabetes-specific self-efficacy (DES-SF). Results: Insulin was perceived to be very important, and its benefits (e.g. improves health) were endorsed by most (82%). Fifty-one per cent believed that taking insulin means their diabetes has become worse; 51% that insulin causes weight gain; 39% that they have 'failed to manage' their diabetes. Those with the greatest and least 'ITAS negative' scores did not differ by diabetes duration or years using insulin, or by average number of insulin injections or blood glucose checks per day. Those with more negative insulin appraisals were significantly younger (Mean Diff. = 5 years, P < 0.001), less satisfied with recent blood glucose levels (P < 0.001, d = 0.63), had reduced diabetes-specific self-efficacy (P < 0.001, d = 0.7), and were more likely to report depressive symptoms, anxiety or diabetes distress (all P < 0.001, d = 0.65-1.1). Conclusions: Negative insulin therapy appraisals are common among adults with Type 2 diabetes using insulin, and are associated with lower general and diabetes-specific emotional well-being, reduced diabetes-specific self-efficacy and satisfaction with blood glucose. What's new?: This is the first study to explicitly explore appraisals of insulin therapy among adults with Type 2 diabetes currently using insulin using validated measures. Despite insulin use, some people with Type 2 diabetes report negative appraisals of insulin therapy including physical and psychological barriers. Diabetes duration, years using insulin, injections and blood glucose checks per day do not differ between those with more and those with less negative appraisals of insulin therapy. Participants reporting more negative insulin appraisals also report poorer general and diabetes-specific emotional well-being, reduced diabetes-specific self-efficacy and satisfaction with blood glucose levels compared with those with more positive appraisals.
UR - http://www.scopus.com/inward/record.url?scp=84941934341&partnerID=8YFLogxK
U2 - 10.1111/dme.12729
DO - 10.1111/dme.12729
M3 - Journal article
C2 - 25683652
AN - SCOPUS:84941934341
SN - 1464-5491
VL - 32
SP - 1297
EP - 1303
JO - Diabetic Medicine Online
JF - Diabetic Medicine Online
IS - 10
ER -
